Effect of cisplatin on the clock genes expression in the liver, heart and kidney

Biochem Biophys Res Commun. 2018 Jun 22;501(2):593-597. doi: 10.1016/j.bbrc.2018.05.056.

Abstract

Cisplatin is a platinum-based chemotherapy drug that is widely used to treat various types of malignancies. Although the involvement of circadian clock in cisplatin metabolism and excretion has been reported, the effect of cisplatin on circadian rhythm remains unclear. In the present study, we investigated the effects of cisplatin on clock genes expression in mouse peripheral tissues. Cisplatin induced severe nephrotoxicity, as revealed by the significant increase of blood urea nitrogen and serum creatinine levels. Moreover, cisplatin circadian time-dependently induced p21 expression in the liver, heart and kidney, with the highest increase during the dark phase. In addition, cisplatin altered the clock genes expression in the liver, heart and kidney in a tissue- and gene-specific manner. Interesting, the expression of D site of the albumin promoter binding protein (Dbp), a gene involved in detoxification and drug metabolism, was consistently suppressed in the liver, heart and kidney after cisplatin treatment, implying a role of DBP in the toxicity of cisplatin.

Keywords: Circadian rhythm; Cisplatin; Tissue function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / adverse effects*
  • Body Weight / drug effects
  • CLOCK Proteins / genetics*
  • Cisplatin / adverse effects*
  • Gene Expression Regulation / drug effects*
  • Heart / drug effects*
  • Kidney / drug effects*
  • Kidney / metabolism
  • Liver / drug effects*
  • Liver / metabolism
  • Mice

Substances

  • Antineoplastic Agents
  • CLOCK Proteins
  • Cisplatin